Sharecafe

Developing therapeutics to reduce brain damage after stroke

Presenter - Liz Dallimore - CEO - Argenica Therapeutics Limited researches and develops a neuroprotective therapeutic drug in Australia.

Presenter – Liz Dallimore – CEO – Argenica Therapeutics Limited is developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories